Increasing Efficiency in Drug Discovery & Development with Aptuit Medicines Research CentreHosted By: Andrea Charles
Tags : aptuit | cro | clinical development | biomarker | Mauro Corsi | Phil Gerrard | Assay Development | Vitro Profiling | Preclinical Technologies | Sergio Raimondo | Preclinical Safety | Preclinical Pharmacology | Mark Hembarsky | Stefano Zancan | Clinical Trial Management | therapeutic candidates | investment | early clinical development | sponsor-CRO
About this Podcast...
In this podcast Mark Hembarsky, Vice President and Site Leader of the Aptuit Medicines Research Centre in Verona, Italy, and his colleagues Mauro Corsi, Head of Assay Development and In Vitro Profiling Preclinical Technologies, Sergio Raimondo, Head of Scientific Strategy Preclinical Safety, Phil Gerrard Head of Preclinical Pharmacology and Stefano Zancan, Head of Clinical Trial Management, join Andrea Charles from Pharma IQ, to share their scientific and technological expertise and provide an insight into the Aptuit Medicines Research Centre.
In this interview they discuss improving the success rates of therapeutic candidates in clinical development, making more efficient go/no-go decisions, challenges and investment considerations for biomarkers in early clinical development and the changing dynamics of the sponsor-CRO relationship.
Have Your Say
Rate this feature and give us your feedback in the comments section below
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.
comments powered by Disqus
Discovery Partnerships 2014
Mövenpick Hotel, Berlin, Germany
May 19- 20, 2014
Pharmaceutical Packaging and Labelling - June 2014
Pullman Basel Europe, Basel, Switzerland
June 10- 12, 2014
DoubleTree by Hilton Hotel, San Diego, CA
June 16- 18, 2014
LIMS and the Lab Informatics Landscape
April 10, 2014
Comparators – New GDP Rules, Emerging Markets, to Site Distribution and Partnerships - How Will They Affect Your Comparator Procurement
January 15, 2014